Beispiel fuer einen GenomicStudyAnalysis - MII IG Kerndatensatz-Modul Molekulares Tumorboard v2027.0.0-ballot.1

MII IG Kerndatensatz-Modul Molekulares Tumorboard
2027.0.0-ballot.1 - Germany

This page is part of the MII Implementation Guide Molecular Tumor Board (v2027.0.0-ballot.1: Release) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions

Beispiel Procedure: Beispiel fuer einen GenomicStudyAnalysis

German

Profile: MII PR MTB Genomic Study Analysis version: 2027.0.0-ballot.1

Genomic Study Analysis Method Type: Next-Generation (NGS)/Massively parallel sequencing (MPS)

Genomic Study Analysis Focus: Maxim Muster (no stated gender), DoB Unknown

Genomic Study Analysis Device
device: Device: manufacturer = Illumina
function: Sequenziergerät

Genomic Study Analysis Device
device: Device: manufacturer = Illumina
function: Sequenzier-Kit

Genomic Study Analysis Device
device: Device: manufacturer = Illumina
function: Library-Preparation Kit

Genomic Study Analysis Genome Build: GRCh38

status: Completed

category: Laboratory

subject: Maxim Muster (no stated gender), DoB Unknown

IG © 2024+ Medizininformatik-Initiative. Package de.medizininformatikinitiative.kerndatensatz.mtb#2027.0.0-ballot.1 basiert auf FHIR 4.0.1. Erstellt 2026-09-15
Links: Inhaltsverzeichnis | QA-Bericht | netzwerk-universitaetsmedizin.de | medizininformatik-initiative.de | Impressum
HL7®, FHIR® and the FHIR flame design are registered trademarks of Health Level Seven International. Their use does not constitute endorsement by HL7.